MXPA04005151A - Compuestos terapeuticos. - Google Patents
Compuestos terapeuticos.Info
- Publication number
- MXPA04005151A MXPA04005151A MXPA04005151A MXPA04005151A MXPA04005151A MX PA04005151 A MXPA04005151 A MX PA04005151A MX PA04005151 A MXPA04005151 A MX PA04005151A MX PA04005151 A MXPA04005151 A MX PA04005151A MX PA04005151 A MXPA04005151 A MX PA04005151A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- therapeutic compounds
- formula
- well
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K51/047—Benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33401201P | 2001-11-28 | 2001-11-28 | |
| PCT/US2002/037715 WO2003045940A2 (en) | 2001-11-28 | 2002-11-26 | Benzazepine derivatives and their use as 5-ht ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04005151A true MXPA04005151A (es) | 2004-08-11 |
Family
ID=23305178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04005151A MXPA04005151A (es) | 2001-11-28 | 2002-11-26 | Compuestos terapeuticos. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6861420B2 (enExample) |
| EP (1) | EP1451176A2 (enExample) |
| JP (1) | JP2005535560A (enExample) |
| AU (1) | AU2002346507A1 (enExample) |
| BR (1) | BR0214529A (enExample) |
| CA (1) | CA2468010A1 (enExample) |
| MX (1) | MXPA04005151A (enExample) |
| WO (1) | WO2003045940A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04008517A (es) * | 2002-03-04 | 2005-08-19 | Pharmacia & Upjohn Co Llc | Compuestos terapeuticos. |
| TW200510324A (en) * | 2003-08-11 | 2005-03-16 | Lilly Co Eli | 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| CA2556390C (en) | 2004-02-25 | 2012-10-02 | Eli Lilly And Company | 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| EP1728520A1 (de) * | 2005-05-04 | 2006-12-06 | Charité - Universitätsmedizin Berlin | Verwendung von spezifisch an das Serotonin-Transport-Protein (SERT) bindenden Radiopharmaka zur Herstellung eines Diagnostikums zur Untersuchung von Kopfschmerzerkrankungen |
| WO2006117218A2 (en) * | 2005-05-04 | 2006-11-09 | Charite Universitätsmedizin - Berlin | Serotonin-transport-protein binding radiopharmaceutical for the production of a diagnostic medicament for the diagnosis of headache |
| EP1924561B1 (en) | 2005-09-01 | 2012-11-14 | Eli Lilly & Company | 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| US8420631B2 (en) * | 2005-09-01 | 2013-04-16 | Eli Lilly And Company | 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| WO2007028132A2 (en) * | 2005-09-01 | 2007-03-08 | Eli Lilly And Company | 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| PT1924560E (pt) * | 2005-09-01 | 2009-10-23 | Lilly Co Eli | 2,3,4,5-tetra-hidro-1h-benzo[d]azepinas como agonistas de receptores 5-ht2c |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132311A (en) * | 1990-06-27 | 1992-07-21 | G. D. Searle & Co. | Cyanoquanidine type III antiarrhythmic agents and use |
| GB9612883D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| GB9612885D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| AU2001264376A1 (en) * | 2000-06-15 | 2001-12-24 | Chaconne Nsi Co., Ltd. | Urea derivative useful as an anti-cancer agent and process for preparing same |
-
2002
- 2002-11-26 JP JP2003547390A patent/JP2005535560A/ja not_active Withdrawn
- 2002-11-26 WO PCT/US2002/037715 patent/WO2003045940A2/en not_active Ceased
- 2002-11-26 CA CA002468010A patent/CA2468010A1/en not_active Abandoned
- 2002-11-26 AU AU2002346507A patent/AU2002346507A1/en not_active Abandoned
- 2002-11-26 US US10/305,408 patent/US6861420B2/en not_active Expired - Fee Related
- 2002-11-26 EP EP02784572A patent/EP1451176A2/en not_active Withdrawn
- 2002-11-26 BR BRPI0214529-4A patent/BR0214529A/pt not_active IP Right Cessation
- 2002-11-26 MX MXPA04005151A patent/MXPA04005151A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005535560A (ja) | 2005-11-24 |
| AU2002346507A1 (en) | 2003-06-10 |
| US6861420B2 (en) | 2005-03-01 |
| US20030149024A1 (en) | 2003-08-07 |
| AU2002346507A8 (en) | 2003-06-10 |
| WO2003045940A3 (en) | 2003-09-12 |
| BR0214529A (pt) | 2006-05-30 |
| WO2003045940A2 (en) | 2003-06-05 |
| EP1451176A2 (en) | 2004-09-01 |
| CA2468010A1 (en) | 2003-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0104140D0 (sv) | Novel Compounds | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| MXPA02012425A (es) | Compuestos nuevos. | |
| MXPA03008754A (es) | Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor. | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| DE60112609D1 (en) | Pyrazolopyridine | |
| SE0202539D0 (sv) | Compounds | |
| MXPA04004498A (es) | Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion. | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| SE0200920D0 (sv) | Novel compounds | |
| GEP20084329B (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension | |
| SE0202133D0 (sv) | Novel compounds | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| MXPA04000577A (es) | Derivados de dolastatina 10. | |
| MY128924A (en) | Novel compounds | |
| WO2004106293A3 (en) | Oxazolyl - and thiazolyl - purine based tricyclic compounds. | |
| DE60112330D1 (en) | Pyrazolopyridinderivate | |
| SE0302139D0 (sv) | Novel compounds | |
| MXPA04001968A (es) | Agentes antidiabeticos. | |
| TW200604197A (en) | New compounds | |
| IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| IL147149A0 (en) | Novel diphenyl-piperidine derivate |